Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics.
Hulton CH, Costa EA, Shah NS, Quintanal-Villalonga A, Heller G, de Stanchina E, Rudin CM, Poirier JT
Nat Cancer. 2020 Mar;1(3):359-369. doi: 10.1038/s43018-020-0040-8. Epub 2020 Mar 9.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
114010pSpCTRE-CD4Dox-inducible Cas9 expression with a CD4 selection marker
114011sgTrack-Gateway3rd generation lentiviral empty sgRNA expression vector with a Gateway cassette for co-expression of a reporter cDNA
114012sgTrack-GFPEmpty sgRNA expression vector with co-expression of TurboGFP reporter
114013sgTrack-mCherryEmpty sgRNA expression vector with co-expression of mCherry reporter

Antibodies from Article